Company / Inventory
Amylyx Pharmaceuticals, Inc. Inventory History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$38.3M
FY2023
5-year range
$9.8M / $38.3M
FY2022-FY2023
Trend
+292.3%
vs FY2022
Sector context
#64 of 105
Health Care
What the data says
At $38M, Amylyx Pharmaceuticals, Inc.'s inventory ranks #64 of 105 in the Health Care sector.
Based on SEC 10-K filings.
$38M in FY2023.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#64 of 105 in Health CareTop 61% of 105This company $38.3M Sector average $885.3M
▼
-95.7% below sector average
Key checks
Key Insights
- In FY2023, inventory increased 292.3% year-over-year.
- Ranks #64 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $38.3M | +292.3% |
| FY2022 | $9.8M | - |
| FY2021 | - | - |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026